Effects of Rifaximin on Circulating Albumin Structures and Serum Ammonia Levels in Patients with Liver Cirrhosis: A Preliminary Study

Circulating albumin structures, including their oxidized and reduced forms, are involved in hepatic encephalopathy (HE) development. However, the effects of rifaximin, a key drug in HE treatment, on the circulating albumin structure in patients with liver cirrhosis remain unclear. In this multicente...

Descripción completa

Detalles Bibliográficos
Autores principales: Miwa, Takao, Hanai, Tatsunori, Imai, Kenji, Takai, Koji, Shiraki, Makoto, Hayashi, Hideki, Shimizu, Shogo, Nishigaki, Yoichi, Tomita, Eiichi, Shimizu, Masahito
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9784744/
https://www.ncbi.nlm.nih.gov/pubmed/36555935
http://dx.doi.org/10.3390/jcm11247318

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9784744/
https://www.ncbi.nlm.nih.gov/pubmed/36555935
http://dx.doi.org/10.3390/jcm11247318

Ejemplares similares